| Title: |
LBA102 THOR-2 cohort 1: Results of erdafitinib (ERDA) vs intravesical chemotherapy (chemo) in patients (pts) with high-risk non–muscle-invasive bladder cancer (HR NMIBC) with select fibroblast growth factor receptor alterations (FGFRALT) who received prior bacillus calmette-guérin (BCG) treatment |
| Authors: |
Catto, J.W.F.; Tran, B.; Roupret, M.; Gschwend, J.E.; Loriot, Y.; Nishiyama, H.; Palou, J.; Daneshmand, S.; Hussain, S.A.; Cutuli, H.J.; Procopio, G.; Guadalupi, V.; Vasdev, N.; Naini, V.; Crow, L.; Triantos, S.; Baig, M.; Steinberg, G.D. |
| Source: |
Annals of Oncology ; volume 34, page S1341-S1342 ; ISSN 0923-7534 |
| Publisher Information: |
Elsevier BV |
| Publication Year: |
2023 |
| Collection: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1016/j.annonc.2023.10.108 |
| Availability: |
http://dx.doi.org/10.1016/j.annonc.2023.10.108; https://api.elsevier.com/content/article/PII:S0923753423042722?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S0923753423042722?httpAccept=text/plain |
| Rights: |
https://www.elsevier.com/tdm/userlicense/1.0/ ; https://www.elsevier.com/legal/tdmrep-license ; http://www.elsevier.com/open-access/userlicense/1.0/ |
| Accession Number: |
edsbas.F77953B0 |
| Database: |
BASE |